Thiophenylaminoimidazolines as IP antagonists
US7078401B2 · kind B2 · utility
2Cited by
6References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 9, 2004 |
| Grant date | Jul 18, 2006 |
| Priority date | — |
| Expiry date | Jul 27, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for treatment of IP antagonist mediated diseases or conditions by administration to a subject in need thereof a compound of formula (I)wherein R1, R2, A and X are as defined herein. Also disclosed are compounds and related compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.